Enhanced Antitumor Effect of the Combination of Bacille Calmette-Guérin and an Immune Checkpoint Inhibitor in Bladder Cancer-On-a-Chip-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhanced Antitumor Effect of the Combination of Bacille Calmette-Guérin and an Immune Checkpoint Inhibitor in Bladder Cancer-On-a-Chip

Published:2023-10-17 Issue:4 Volume:17 Page:496-506
ISSN:1976-0280
Container-title:BioChip Journal
language:en
Short-container-title:BioChip J

Author:

Choi Se Young,Kim Mirinae,Kang Su Jeong,Choi Young Wook,Maeng Sejung,Kim Sung-Hwan,Chang In Ho

Funder

National Research Foundation of Korea

Publisher

Springer Science and Business Media LLC

Subject

Electrical and Electronic Engineering,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s13206-023-00125-z.pdf

Reference24 articles.

1. Takeda, T., et al.: Discontinuance of bacille Calmette-Guérin instillation therapy for nonmuscle-invasive bladder cancer has negative effect on tumor recurrence. Urology 73, 1318–1322 (2009). https://doi.org/10.1016/j.urology.2008.12.039

2. Patel, V.G., Oh, W.K., Galsky, M.D.: Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J. Clin. 70, 404–423 (2020). https://doi.org/10.3322/caac.21631

3. Balar, A.V., et al.: Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study. Lancet Oncol. 22, 919–930 (2021). https://doi.org/10.1016/S1470-2045(21)00147-9

4. Lopez-Beltran, A., et al.: Immune checkpoint inhibitors for the treatment of bladder cancer. Cancers (Basel). 13, 131 (2021). https://doi.org/10.3390/cancers13010131

5. Wei, S.C., Duffy, C.R., Allison, J.P.: Fundamental Mechanisms of Immune Checkpoint Blockade Therapy. Cancer Discov. 8, 1069–1086 (2018). https://doi.org/10.1158/2159-8290.CD-18-0367

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3